Search

everythinglearnresearchcommunity

for

Search:↓

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Animals that change color with the seasons mainly do so in response to daylight changes, but climate change is causing camouflage problems that may require evolutionary changes.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Hormonal therapies are safe and effective for treating adult women's acne.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Two mouse mutations cause similar hair loss despite different skin changes.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Tandem repeats significantly influence hair color, especially darker shades, across different ancestries.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.